New efficient substrates for semicarbazide-sensitive amine oxidase/VAP-1 enzyme: Analysis by SARs and computational docking

Journal of Medicinal Chemistry

Volumn 49, Issue 21, 2006, Pages 6197-6208

  Yraola, Francesc ^a   García Vicente, Silvia ^b   Fernández Recio, Juan ^b   Albericio, Fernando ^b,c   Zorzano, Antonio ^b,c   Marti, Luc ^b   Royo, Miriam ^a  

^a Barcelona Science Park ^*  (Spain)

^b INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

2 (4 FLUOROPHENYL)ETHYLAMINE; 3 FLUORO 4 METHYLBENZYLAMINE; 3 PHENYLPROPYLAMINE; 4 BUTYLBENZYLAMINE; 4 ETHYLBENZYLAMINE; 4 FLUOROBENZYLAMINE; 4 PHENYLBUTYLAMINE; 4 TRIFLUOROMETHYLBENZYLAMINE; ALDOXIME; AMINE OXIDASE (COPPER CONTAINING); ARALKYLAMINE; PHENETHYLAMINE; UNCLASSIFIED DRUG; VASCULAR ADHESION PROTEIN 1;

ADIPOCYTE; ANIMAL CELL; ARTICLE; COMBINATORIAL CHEMISTRY; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME KINETICS; ENZYME METABOLISM; ENZYME SPECIFICITY; ENZYME SUBSTRATE; GLUCOSE TRANSPORT; MOLECULAR MODEL; MOUSE; NONHUMAN; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RAT; STRUCTURE ACTIVITY RELATION;

ADIPOCYTES; AMINE OXIDASE (COPPER-CONTAINING); ANIMALS; BENZYLAMINES; BIOLOGICAL TRANSPORT; CELL ADHESION MOLECULES; DATABASES, FACTUAL; GLUCOSE; HUMANS; HYPOGLYCEMIC AGENTS; KINETICS; MICE; MODELS, MOLECULAR; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; RATS; SUBSTRATE SPECIFICITY;

EID: 33750138764     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm051076e     Document Type: Article

References (34)

1. Murray, M. J.; Saysell, C. G.; Wilmot, C. M.; Tambyrajah, W. S.; Jaeger, J.; Knowles, P. F.; Pillips, S.; McPherson, M. J. The active site base controls cofactor reactivity in Escherichia coli amine oxidase: X-ray crystallographic studies with mutational variants. Biochemistry 1999, 38, 8217-8227.
2. Jalkannen, S.; Salmi, M. Cell surface monoamine oxidases: enzymes in search of a function. EMBO J. 2001, 20, 3893-3901.
3. Morris, N. J.; Ducret, A.; Aebersold, R.; Ross, S. A.; Keller, S. R.; Lienhard, G. E. Membrane amine oxidase cloning and identification as a major protein in the adipocyte plasma membrane. J. Biol. Chem. 1997, 272, 9388-9392.
4. Enrique-Tarancón, G.; Marti, L.; Morin, M.; Lizcano, J., M.; Unzeta, M.; Sevilla, L.; Camps, M.; Palacín, M.; Testar, X.; Carpéné, C.; Zorzano, A. Role of semicarbazide-sensitive amine oxidase on glucose transport and GLUT4 recruitment to the cell surface in adipose cells. J. Biol. Chem. 1998, 273, 8025-8032.
5. Marti, L.; Morin, M.; Enrique-Tarancón, G.; Prevot, D.; Lafontan, M.; Testar, X.; Zorzano, A.; Carpéné, C. Tyramine and vanadate synergistically stimulate glucose transport in rat adipocytes by amine oxidase-dependent generation of hydrogen peroxide. J. Pharmacol. Exp. Ther. 1998, 285, 342-349.
6. Morin, M.; Visentin, V.; Calisse, D.; Marti, L.; Zorzano, A.; Testar, X.; Valet, P.; Fischer, Y.; Carpéné, C. Tyramine stimulates glucose uptake in insulin-sensitive tissues in vitro and in vivo via its oxidation by amine oxidases. J. Pharmacol. Exp. Ther. 2002, 303, 1238-1247.
7. Morin, N.; Lizcano, J. M.; Fontana, E.; Marti, L., Smih, F.; Rouet, P.; Prevot, D.; Zorzano, A.; Unzeta, M.; Carpéné, C. Semicarbazide-sensitive amine oxidase substrates stimulate glucose transport and inhibit lipolysis in human adipocytes. J Pharmacol. Exp. Ther. 2001, 297, 563-572.
8. Fontana, E.; Boucher, J.; Marti, L.; Lizcano, J. M.; Testar, X., Zorzano, A.; Carpéné, C. Amine oxidase substrates mimic several of the insulin effects on adipocyte differentiation in 3T3 F442A cells. Biochem J. 2001, 356, 769-777.
9. Abella, A.; Marti, L.; Camps, M.; Claret, M.; Fernández-Alvarez, J.; Gomis, R.; Gumà, A.; Viguerie, N.; Carpéné, C.; Palacín, M.; Testar, X.; Zorzano, A. Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 activity exerts an antidiabetic action in Goto-Kakizaki rats. Diabetes 2003, 52, 1004-1013.
10. Marti, L.; Abella, A.; Carpéné, C.; Palacín, M.; Testar, X.; Zorzano, A. Combined treatment with benzylamine and low dosages of vanadate enhances glucose tolerance and reduces hyperglycemia in streptozotocin-induced diabetic rats. Diabetes 2003, 50, 2061-2068.
11. Zorzano, A.; Abella, A.; Marti, L.; Carpéné, C.; Palacín, M.; Testar, X. Semicarbazide-sensitive amine oxidase activity exerts insulin-like effects on glucose metabolism and insulin-signaling pathways in adipose cells. Biochim. Biophys. Acta 2003, 1647, 3-9.
12. Yu, P. H.; Zuo, D. M. Oxidative deamination of methylamine by semicarbazide-sensitive amine oxidase leads to cytotoxic damage in endothelial cells. Possible consequences for diabetes. Diabetes 1993, 42, 594-603.
13. Marti, L.; Abella, A.; De la Cruz, X.; García-Vicente, S.; Unzeta, M.; Carpéné, C.; Palacín, M.; Testar, X.; Orozco, M.; Zorzano, A. Exploring the binding mode of semicarbazide-sensitive amine oxidase/VAP-1: identification of novel substrates with insulin-like activity. J. Med. Chem. 2004, 47, 4865-4874.
14. Bair, K. W.; Tuttle, R. L.; Knick, V. C.; Cory, M.; McKee, D.D. [(1-Pyrenylmethyl)amino]alcohols, a new class of antitumor DNA intercalators. Discovery and initial amine side chain structure-activity studies. J. Med. Chem. 1990, 33, 2385-2393.
15. Scozzafava, A.; Supuran, C. T. Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes. J. Med. Chem., 2000, 43, 3677-3687.
16. Lyles, G. A. Substrate-specificity of mammalian tissue-bound semicarbazide-sensitive amine oxidase. Prog. Brain Res. 1995, 106, 293-303.
17. Wilce, M. C. J.; Dooley, D. M.; Freeman, H. C.; Guss, J. M.; Matsunami, H.; McIntire, W. S.; Ruggiero, C. E.; Tanizawa, K.; Yamaguchi, H. Crystal structures of the copper-containing amine oxidase from Arthrobacter globiformis in the holo and apo forms: implications for the biogenesis of topaquinone. Biochemistry 1997, 36, 16116-16133.
18. Salminen, T. A.; Smith, D. J.; Jalkanen, S.; Johnson, M. S. Structural model of the catalytic domain of an enzyme with cell adhesion activity: human vascular adhesion protein-1 (HVAP-1) D4 domain is an amine oxidase. Protein Eng. 1998, 11, 1195-1204.
19. Lunelli, M.; Di Paolo, M. L.; Biadene, M.; Calderone, V.; Battistutta, R.; Scarpa, M.; Rigo, A.; Zanotti, G. Crystal structure of amine oxidase from bovine serum. J. Mol. Biol. 2005, 346, 991-1004.
20. Liang, J.; Edelsbrunner, H.; Woodward, C. Anatomy of protein pockets and cavities: measurement of binding site geometry and implications for ligand design. Protein Sci. 1998, 7, 1884-1897.
21. Salmi, M.; Yegutkin, G. G.; Lehvonen, R.; Koskinen, K.; Salminen, T.; Jalkanen, S. A cell surface amine oxidase directly controls lymphocyte migration. Immunity 2001, 14, 265-276.
22. Lyles, G. A. Substrate-specificity of mammalian tissue-bound semicarbazide-sensitive amine oxidase. Prog. Brain Res. 1995, 106, 293-303.
23. Wilmot, C. M.; Murray, J. M.; Alton, G.; Parsons, M. R.; Convery, M. A.; Blakeley, V.; Corner, A. S.; Palcic, M. M.; Knowles, P. F.; McPherson, M. J.; Phillips, S. E. V. Catalytic mechanism of the quinoenzyme amine oxidase from Escherichia coli: exploring the reductive half-reaction. Biochemistry 1997, 36, 1608-1620.
24. Zhou, M.; Panchuk-Voloshina, N. A one-step fluorometric method for the continuous measurement of monoamine oxidase activity. Anal. Biochem. 1997, 253, 169-174.
25. Sali, A.; Blundell, T. L. Comparative protein modeling by satisfaction of spatial restraints. J. Mol. Biol. 1993, 234, 779-815.
26. Bernstein, F. C.; Koetzle, T. F.; Williams, G. J.; Meyer, E. F., Jr.; Brice, M. D.; Rodgers, J. R.; Kennard, O.; Shimanouchi, T.; Tasumi, M. The protein data bank: a computer-based archival file for macromolecular structures. J. Mol. Biol. 1977, 112, 535-542.
27. Airenne, T. T.; Nymalm, Y.; Kidron, H.; Smith, D. J.; Pihlavisto, M.; Salmi, M.; Jalkanen, S.a; Johnson, M. S.; Salminen, T. A. Crystal structure of the human vascular adhesion protein-1: Unique structural features with functional implications. Protein Sci. 2005, 14, 1964-1974.
28. Laskowski, R. A.; MacArthur, M. W.; Moss, D. S.; Thornton, J. M. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 1993, 26, 283.
29. Phillips, J. C.; Braun, R.; Wang, W.; Gumbart, J.; Tajkhorshid, E.; Villa, E.; Chipot, C.; Skeel, R. D.; Kale, L.; Schulten, K. Scalable molecular dynamics with NAMD. J. Comput. Chem. 2005, 26, 1781-1802.
30. Wang, J.; Cieplak, P.; Kollman, P. A. How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules? J. Comput. Chem. 2000, 21, 1049-1074.
31. Allinger, N. L.; Yuh, Y. H.; Lii, J. H. Molecular mechanics. The MM3 force field for hydrocarbons. 1. J. Am. Chem. Soc. 1989, 111, 8551-8566.
32. Ponder, J. W.; Richards, F. M. An efficient Newton-like method for molecular mechanics energy minimization of large molecules. J. Comput. Chem. 1987, 8, 1016-1024.
33. Gelpi, J. L.; Kalko, S. G.; Barril, X.; Cirera, J.; de La Cruz, X.; Luque, F. J.; Orozco, M. Classical molecular interaction potentials: improved setup procedure in molecular dynamics simulations of proteins. Proteins 2001, 45, 428-437.
34. Pearlman, D. A.; Case, D. A.; Caldwell, J. W.; Ross, W. S.; Cheatham, T. E., III; DeBolt, S.; Ferguson, D.; Seibel, G.e; Kollman, P. "AMBER", a package of computer programs for applying molecular mechanics, normal-mode analysis, molecular dynamics and free energy calculations to stimulate the structural and energetic properties of molecules. Comput. Phys. Commun. 1995, 91, 1-42.